10.04.17
Thinfilm has announced that GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies, has commercially deployed Thinfilm’s SpeedTap tags to create interactive "smart" shelves for enhanced communication with consumers at time of purchase decision-making.
GSK introduced interactive smart Flonase shelves in retail stores across Canada in an effort to educate consumers about the new product and guide them in their purchasing decision. Thinfilm’s SpeedTap tags incorporated into shelving allow consumers to obtain product information through the tap of an NFC-enabled smartphone.
In addition to SpeedTap tags, GSK is also using Thinfilm’s software platform – CNECT – as part of the end-to-end solution that helps dynamically manage the experience of Flonase consumers. The cloud-based platform integrates with the NFC hardware, enabling GSK to manage tags remotely, deliver custom messaging and content, view real-time consumer tapping activity and develop valuable consumer insights through built-in analytics functionality.
“At GSK, we focus on helping people do more, feel better, and live longer. And we do that, in large part, by delivering highly effective products to the market,” says Sriman Banerjee, director – R&D Respiratory Packaging for GSK. “But we also realize that connecting directly with consumers to provide unique and meaningful experiences is critical in today’s market. We believe an innovative mobile technology like Thinfilm’s can play a critical role in strengthening customer relationships, building brand loyalty, and driving revenue for the Flonase brand.”
Flonase Allergy Relief is the first "prescription to over-the-counter" intranasal corticosteroid spray from GSK indicated for relief of nasal and eye-related allergy symptoms, as well as management of sinus pain and pressure. It is used for seasonal and year-round allergy symptoms caused by pollen, mold, dust and pets.
“We are delighted to work with GSK – a global leader, an innovator, and a company that is changing the face of healthcare,” says Davor Sutija, CEO of Thinfilm. “Bringing Thinfilm’s NFC solutions to a valued product like Flonase is a milestone in the industry, and we look forward to helping GSK drive the brand’s value by connecting directly with consumers at the time of purchase decision-making.”
GSK introduced interactive smart Flonase shelves in retail stores across Canada in an effort to educate consumers about the new product and guide them in their purchasing decision. Thinfilm’s SpeedTap tags incorporated into shelving allow consumers to obtain product information through the tap of an NFC-enabled smartphone.
In addition to SpeedTap tags, GSK is also using Thinfilm’s software platform – CNECT – as part of the end-to-end solution that helps dynamically manage the experience of Flonase consumers. The cloud-based platform integrates with the NFC hardware, enabling GSK to manage tags remotely, deliver custom messaging and content, view real-time consumer tapping activity and develop valuable consumer insights through built-in analytics functionality.
“At GSK, we focus on helping people do more, feel better, and live longer. And we do that, in large part, by delivering highly effective products to the market,” says Sriman Banerjee, director – R&D Respiratory Packaging for GSK. “But we also realize that connecting directly with consumers to provide unique and meaningful experiences is critical in today’s market. We believe an innovative mobile technology like Thinfilm’s can play a critical role in strengthening customer relationships, building brand loyalty, and driving revenue for the Flonase brand.”
Flonase Allergy Relief is the first "prescription to over-the-counter" intranasal corticosteroid spray from GSK indicated for relief of nasal and eye-related allergy symptoms, as well as management of sinus pain and pressure. It is used for seasonal and year-round allergy symptoms caused by pollen, mold, dust and pets.
“We are delighted to work with GSK – a global leader, an innovator, and a company that is changing the face of healthcare,” says Davor Sutija, CEO of Thinfilm. “Bringing Thinfilm’s NFC solutions to a valued product like Flonase is a milestone in the industry, and we look forward to helping GSK drive the brand’s value by connecting directly with consumers at the time of purchase decision-making.”
